These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22075249)

  • 1. Clinical and genetic association of serum ceruloplasmin with cardiovascular risk.
    Tang WH; Wu Y; Hartiala J; Fan Y; Stewart AF; Roberts R; McPherson R; Fox PL; Allayee H; Hazen SL
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):516-22. PubMed ID: 22075249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk.
    Tang WH; Hartiala J; Fan Y; Wu Y; Stewart AF; Erdmann J; Kathiresan S; ; Roberts R; McPherson R; Allayee H; Hazen SL
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2803-12. PubMed ID: 22982463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma ceruloplasmin, a regulator of nitric oxide activity, and incident cardiovascular risk in patients with CKD.
    Kennedy DJ; Fan Y; Wu Y; Pepoy M; Hazen SL; Tang WH
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):462-7. PubMed ID: 24311705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study.
    Dadu RT; Dodge R; Nambi V; Virani SS; Hoogeveen RC; Smith NL; Chen F; Pankow JS; Guild C; Tang WH; Boerwinkle E; Hazen SL; Ballantyne CM
    Circ Heart Fail; 2013 Sep; 6(5):936-43. PubMed ID: 23861484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of elevated serum ceruloplasmin levels in patients with heart failure.
    Hammadah M; Fan Y; Wu Y; Hazen SL; Tang WH
    J Card Fail; 2014 Dec; 20(12):946-52. PubMed ID: 25128745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of the proinflammatory chitin-binding glycoprotein YKL-40, variation in the chitinase 3-like 1 gene (CHI3L1), and incident cardiovascular events.
    Ridker PM; Chasman DI; Rose L; Loscalzo J; Elias JA
    J Am Heart Assoc; 2014 Jun; 3(3):e000897. PubMed ID: 24958781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.
    Li XM; Tang WH; Mosior MK; Huang Y; Wu Y; Matter W; Gao V; Schmitt D; Didonato JA; Fisher EA; Smith JD; Hazen SL
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1696-705. PubMed ID: 23520163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating ceruloplasmin, ceruloplasmin-associated genes and the incidence of venous thromboembolism in the Atherosclerosis Risk in Communities study.
    Arenas de Larriva AP; Alonso A; Norby FL; Roetker NS; Folsom AR
    J Thromb Haemost; 2019 May; 17(5):818-826. PubMed ID: 30803124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of cumulative atherogenic index of plasma (AIP) for cardiovascular outcomes: a prospective community-based cohort study.
    Liu Z; Zhang L; Wang L; Li K; Fan F; Jia J; Li J; Zhang Y
    Cardiovasc Diabetol; 2024 Jul; 23(1):264. PubMed ID: 39026310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study.
    Arenas de Larriva AP; Norby FL; Chen LY; Soliman EZ; Hoogeveen RC; Arking DE; Loehr LR; Alonso A
    Int J Cardiol; 2017 Aug; 241():223-228. PubMed ID: 28427851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of cardiac biomarker score for risk stratification in stable patients undergoing elective cardiac evaluation across glycemic status.
    Tang WH; Iqbal N; Wu Y; Hazen SL
    Am J Cardiol; 2013 Feb; 111(4):465-70. PubMed ID: 23219176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of a genetic risk score with prevalent and incident myocardial infarction in subjects undergoing coronary angiography.
    Patel RS; Sun YV; Hartiala J; Veledar E; Su S; Sher S; Liu YX; Rahman A; Patel R; Rab ST; Vaccarino V; Zafari AM; Samady H; Tang WH; Allayee H; Hazen SL; Quyyumi AA
    Circ Cardiovasc Genet; 2012 Aug; 5(4):441-9. PubMed ID: 22767652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical myocardial necrosis and cardiovascular risk in stable patients undergoing elective cardiac evaluation.
    Tang WH; Wu Y; Nicholls SJ; Brennan DM; Pepoy M; Mann S; Pratt A; Van Lente F; Hazen SL
    Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):634-40. PubMed ID: 20032289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study.
    di Giuseppe R; Kühn T; Hirche F; Buijsse B; Dierkes J; Fritsche A; Kaaks R; Boeing H; Stangl GI; Weikert C
    Eur J Epidemiol; 2015 Feb; 30(2):131-41. PubMed ID: 25527370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events.
    Lange LA; Carlson CS; Hindorff LA; Lange EM; Walston J; Durda JP; Cushman M; Bis JC; Zeng D; Lin D; Kuller LH; Nickerson DA; Psaty BM; Tracy RP; Reiner AP
    JAMA; 2006 Dec; 296(22):2703-11. PubMed ID: 17164456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detectable subclinical myocardial necrosis is associated with cardiovascular risk in stable patients with diabetes.
    Tang WH; Wu Y; Britt EB; Iqbal N; Hazen SL
    Diabetes Care; 2013 May; 36(5):1126-31. PubMed ID: 23393213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus.
    Wong YK; Cheung CYY; Tang CS; Hai JSH; Lee CH; Lau KK; Au KW; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Cardiovasc Diabetol; 2019 Dec; 18(1):171. PubMed ID: 31847896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
    Gaggin HK; Liu Y; Lyass A; van Kimmenade RR; Motiwala SR; Kelly NP; Mallick A; Gandhi PU; Ibrahim NE; Simon ML; Bhardwaj A; Belcher AM; Harisiades JE; Massaro JM; D'Agostino RB; Januzzi JL
    Circulation; 2017 Jan; 135(2):116-127. PubMed ID: 27881568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble form of receptor for advanced glycation end products and incidence of new cardiovascular events among patients with cardiovascular disease.
    Reichert S; Triebert U; Santos AN; Hofmann B; Schaller HG; Schlitt A; Schulz S
    Atherosclerosis; 2017 Nov; 266():234-239. PubMed ID: 28864204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients.
    Gellen B; Thorin-Trescases N; Sosner P; Gand E; Saulnier PJ; Ragot S; Fraty M; Laugier S; Ducrocq G; Montaigne D; Llaty P; Rigalleau V; Zaoui P; Halimi JM; Roussel R; Thorin E; Hadjadj S
    Diabetologia; 2016 Nov; 59(11):2321-2330. PubMed ID: 27491833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.